Pharmaceutical compositions for the treatment of tumours that express EGFR and ganglioside N-glycolyl GM3 (NEUGCGM3)

摘要

The invention relates to pharmaceutical composition for the treatment of malignant tumours, in particular tumours that express EGFR and N-glycolyl GM3 ganglioside targets, in order to enhance the therapeutic effect produced individually by therapies against said targets. The pharmaceutical compositions of the invention comprise antibodies and/or vaccines against each of the targets. In addition, the invention relates to the methods used to apply the compositions of the invention.